Your browser doesn't support javascript.
loading
Abuses of FDA Regulatory Procedures - The Case of Suboxone.
Haffajee, Rebecca L; Frank, Richard G.
Affiliation
  • Haffajee RL; From the Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor (R.L.H.); and RAND (R.L.H.) and the Department of Health Care Policy, Harvard Medical School (R.G.F.) - both in Boston.
  • Frank RG; From the Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor (R.L.H.); and RAND (R.L.H.) and the Department of Health Care Policy, Harvard Medical School (R.G.F.) - both in Boston.
N Engl J Med ; 382(6): 496-498, 2020 Feb 06.
Article in En | MEDLINE | ID: mdl-31914238
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orphan Drug Production / Buprenorphine / Drugs, Generic / Drug Approval / Government Regulation / Drug Industry / Economic Competition / Buprenorphine, Naloxone Drug Combination / Narcotic Antagonists Limits: Humans Country/Region as subject: America do norte Language: En Journal: N Engl J Med Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orphan Drug Production / Buprenorphine / Drugs, Generic / Drug Approval / Government Regulation / Drug Industry / Economic Competition / Buprenorphine, Naloxone Drug Combination / Narcotic Antagonists Limits: Humans Country/Region as subject: America do norte Language: En Journal: N Engl J Med Year: 2020 Document type: Article Country of publication: